Dr. Stephen Johnston

About the expert

Focus: Early cancer detection and prevention via peptide-array technology

Founder of Calvary, a company developing peptide-array technology for early cancer detection in dogs and people. Approaches cancer through neo-antigen patterns from RNA-processing errors, with a comparative-oncology angle that bridges canine and human disease biology. Has a direct commercial interest in the diagnostic and vaccine work discussed; this does not invalidate the content but is worth knowing when reading performance claims.

Expert discussions with Dr. Stephen Johnston

Dr. Stephen Johnston's discussions are not available yet.